Metraipolis › archive › dc_43aa6fe680bc

Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes? — Europe PMC PMID:42185328

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42185328
DOI: 10.1038/s41525-[numero omesso]-0
License (as archived): solo-consultazione
Archived: 2026-11-01T06:28:49.136Z
SHA-256 of the archived text: dc3d5aa84c97b7243cb0d34438f0cf3293858db743be5e0d734f7bb4babd495f
Stable URL of this page: https://metraipolis.com/documento/dc_43aa6fe680bc

How to cite

Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes? — Europe PMC PMID:42185328 — Europe PMC (en), https://europepmc.org/article/MED/42185328 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43aa6fe680bc (Metraipolis archive dc_43aa6fe680bc, sha256 dc3d5aa84c97b7243cb0d34438f0cf3293858db743be5e0d734f7bb4babd495f)

BibTeX

@misc{dc43aa6fe680bc,
  title = {Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes? — Europe PMC PMID:42185328},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42185328},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43aa6fe680bc; sha256 dc3d5aa84c97b7243cb0d34438f0cf3293858db743be5e0d734f7bb4babd495f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42185328. Agents can read the archived copy with the MCP tool read_document.